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ABSTRACT Apoptosis of photoreceptors occurs infre-
quently in adult retina but can be triggered in inherited and
environmentally induced retinal degenerations. The protoon-
cogene bcl-2 is knoWn to be a potent regulator of cell survival
in neurons.We created lines oftransgenic mice overexpressing
bcl-2 to test for its ability to increase photoreceptor survival.
Bcl-2 increased photoreceptor survival in mice with retinal
degeneration caused by a defective opsin or cGMP phospho-
diesterase. Overexpression of Bcl-2 in normal photoreceptors
also decreased the damaging effects of constant light expo-
sure. Apoptosis was induced in normal photoreceptors by very
high levels of bcl-2. We conclude that bcl-2 is an important
regulator of photoreceptor cell death in retinal degenerations.
Retinitis pigmentosa represents a group of inherited diseases
that result in blindness through destruction of rod and cone
photoreceptors (PRs). The pathogenesis of these retinal de-
generations is largely unexplained, and there are no current
therapies. Studies over the past decade have linked retinitis
pigmentosa to mutations in genes of the phototransduction
cascade, specifically rhodopsin (1), cGMP-phosphodiesterase,
and other PR-specific proteins. Environmental factors also
cause retinal degeneration, the most common being exposure
to intense or constant light. The mechanism by which these
genetic or environmental insults lead to PR cell death is
unknown. Recent studies have demonstrated a common path-
way in several transgenic and naturally occurring animal
models of these blinding diseases. In both inherited (2-5) and
light-induced (6-8) retinal degenerations, PRs die by apopto-
sis. These animal models correlate well with the pathology
observed in human donor retinas affected with retinitis pig-
mentosa (9, 10), and apoptosis in PRs has been seen in early
stages of human retinitis pigmentosa (11).
Apoptosis is an active process involving a set of highly
conserved gene products (12, 13). The orchestrated action of
these genes leads to fragmentation of nuclear DNA, chromo-
somal condensation, breakdown of intracellular material, and
dissolution of the plasma membrane. The debris is quickly
phagocytosed by neighboring cells and produces minimal
inflammatory response.
Regulation of apoptosis occurs through cellular genes that
control entry into the cell death program. bcl-2 is the best
described of these survival-promoting genes. It is a member of a
rapidly expanding family of genes that modulate the survival
response and is a broad and potent inhibitor of apoptosis in many
cell types (14). In cultured neurons, bcl-2 inhibits cell death
caused by many different agents, including growth factor or
glucose withdrawal, application of calcium ionophores, mem-
brane peroxidation, and free radical peroxidation. Whether
bcl-2 can be effective in countering disease progression in vivo
is less clear.
We sought to determine if bcl-2 could interfere with PR
apoptosis in three different models of retinal degeneration.
We overexpressed bcl-2 in PRs of transgenic mice by using a
human bcl-2 expression vector driven by the 5'-flanking region
of opsin. We crossed these mice to two lines of mice that
carried mutations that modeled inherited retinal degeneration
in which different mechanisms trigger apoptosis of PRs. We
also crossed the bcl-2 transgenic mice to normal albino mice
and exposed these animals to several days of constant light, a
condition known to produce apoptotic cell death in PRs.
In the first mQdel, we examined the apoptosis-inhibiting
property of bcl-2 in a line of transgenic mice expressing a
C-terminal truncated form of rhodopsin (15). The expression
of the mutant opsin causes rapid degeneration, presumably
from the inability of the cell to appropriately sort the mutant
opsin in the PR cells (16, 17). PR cell death begins at postnatal
day 8 and is complete by postnatal day 21.
In a second series of experiments, we tested the anti-apoptotic
function of bcl-2 on retinal degeneration caused by a nonfunc-
tional phosphodiesterase in the rd mouse. In homozygous af-
fected rd mice, degeneration of rod PRs begins on postnatal day
10, with loss of most rod cells by postnatal day 20. There are no
surviving rods by 4 weeks of age, but a progressive loss of cones
continues for many months (18). cGMP accumulation in the
retina precedes the degeneration and correlates with deficient
activity of the rod cGMP-phosphodiesterase.
In a third model, we examined the bcl-2 effect on PR
apoptosis in albino mice exposed to sustained illumination. In
this light-damage model, 14 days of sustained illumination
causes apoptotic cell death in the majority of PRs.
In all three models, overexpression of bcl-2 increased the
survival of PRs exposed to an insult known to cause apoptosis.
These results strongly support the idea that retinal degenera-
tions may be treated by modulating the entry of PRs into the
apoptotic cell death pathway.
MATERIALS AND METHODS
Transgene Construction. The opsin/bcl-2 transgene was made
by fusing a O.-75-kb fragment encoding the complete human
cDNA of bcl-2 from the pSFFV expression vector (19) to the
4.4-kb KpnI/XhoI mouse rod opsin 5'-flanking region. The splice
elements were supplied by the simian virus 40 polyadenylylation
signal from pSFFV, producing a 6.4-kb fusion gene construct.
An 11-kb mouse genomic fragment was used to express
rhodopsin in rod PRs of transgenic mice. A stop codon was
created at residue 334 (TCT to TAA) by using site-directed
Abbreviations: PR, photoreceptor; PDE, phosphodiesterase; ONL,
outer nuclear layer.
7042
The publication costs of this article were defrayed in part by page charge
payment. This article must therefore be hereby marked "advertisement" in
accordance with 18 U.S.C. §1734 solely to indicate this fact.
Proc. Natl. Acad. Sci. USA 93 (1996) 7043
mutagenesis. The transgene construct contained -5 kb of 5'
upstream regulatory sequence, all 5 exons and introns, and 1.5
kb of 3' downstream sequence.
Transgenic Mouse Production and Analysis. The truncated
opsin and bcl-2 fusion genes were injected into fertile one-cell
wild-type B6D2 Fl mouse embryos (The Jackson Laborato-
ries). Founder animals for both transgenic lines were identified
by PCR. The oligonucleotide pair used for PCR screening for
the bcl-2 transgene was as follows: amplifying a transgene
fragment using the primers Bcl-2, 5'-CCC TGT TCT CCC
AGC GTG CGG C-3'; and Rh-1, 5'-GAG GAA TTC CCA
GAG GAC TCT GG-3'. Mice expressing the truncated opsin
were identified by PCR analysis as described (20).
Homozygous affected rd/rd mice were identified by screen-
ing for the rd allele by PCR amplification across a nonsense
mutation that creates a DdeI site in the phosphodiesterase
(PDE) 83-subunit cDNA (21).
DNA Laddering Assay. After euthanasia, eyes were enucle-
ated and retinas removed. Total genomic DNA was extracted
from the retina and size-fractionated in a 1.5% agarose gel,
blotted, and probed with 32p labeled mouse genomic DNA.
Tissue Processing for Light Microscopy, Immunocytochem-
istry, and Photoreceptor Morphometry. The procedures were
carried out as described (22). Bcl-2 antibody was a monoclonal
antibody purchased from Cambridge Research Biochemicals
in 1-,um plastic-embedded sections using a calibrated measur-
ing reticule. Surviving PRs were counted in a 180-,um linear
expanse of central retina.
Light Damage and Statistical Analysis. Albino bcl-2 positive
mice (bcl-2/+) of the lower expressing b line were crossed to
albino BALB/c ByJ mice producing '50% each of bcl-2 positive
(bcl-2/+) and wild-type (+/+) progeny. At 2-6 months of age,
the mice were ear-punched for identification 2 days before
constant light exposure, and genomic DNA was prepared from
tail samples to determine the presence or absence of the bcl-2
transgene in the mice. At the same time, one eye was removed
with the mice under Avertin anesthesia and immersion-fixed to
determine the effect of the bcl-2 transgene on PRs in normal
cyclic light. Monocular enucleation has no measurable effect on
constant light damage to the remaining eye (M.M.L., unpublished
observations). Some of the albino bcl-2 positive mice (bcl-2/+)
were crossed to each other to give homozygous wild-type, bcl-2/ +
and bcl-2/bcl-2 genotypes for light damage studies to determine
the effect of two copies of the bcl-2 transgene on retinal PRs both
in cyclic light and constant light.
Mice bred for light damage studies were placed into continuous
fluorescent lighting at an illuminance of 115-130 ft-c for 14 days,
which typically reduces the PR outer nuclear layer (ONL) to 1 row
or less of PR nuclei in the most sensitive region in the superior
hemisphere of the eye as described (23, 24). Histologic sections
cut along the vertical meridian were scored by four observers for
the degree of potential rescue on a scale of 1 (severe damage with
little or no rescue) to 5 (small amount ofdamage to the ONL, with
about 75-85% of PR nuclei remaining). The scores were done
with the observers unaware of the bcl-2 genotype and were based
on ONL thickness in different regions of the eye, as well as PR
inner and outer segment length and integrity. In general, scores
of 1-3 represent the typical range of degeneration seen after 14
days of continuous light in BALB/c mice, which corresponds to
a mean ONL thickness of <5-20 ,um, as described (23). Differ-
ences in the scores of the different genotypes were compared by
using the Student's t test and analysis of variance statistical
measures.
RESULTS
Generation ofTransgenic Mice with a Murine Opsin Promoter
Fused to Human bc1-2 cDNA. We made two lines of transgenic
mice in which PRs overexpressed human bcl-2 by using the
murine opsin promoter (22). Two founders (lines b and c)
expressed different levels of human bcl-2 as determined by
protein immunoblotting (Fig. 1A). A densitometric scan of the
immunoblots demonstrated an 8-fold greater level of Bcl-2 pro-
tein in transgenic line c compared with line b. In nontransgenic
siblings, endogenous Bcl-2 was undetectable with an antibody
against an epitope common to mouse and human. This confirms
the previous finding of low-level expression of the endogenous
Bcl-2 gene in the rat retina (25). We examined the distribution of
Bcl-2 in lines b and c by light and electron microscope immuno-
cytochemistry. Expressed Bcl-2 protein was localized exclusively
to PRs (Fig. 1C), with most of the Bcl-2 immunoreactivity in the
rod synaptic terminals (Fig. 1B). Bcl-2 immunoreactivity was
associated with vesicles in the terminal region above the active
zone (26), and not associated with the prominent mitochondria or
synaptic ribbon in this region.
High Level bcl-2 Expression Causes Apoptosis in Photore-
ceptors. PR cell death was observed in transgenic mice from
line c beginning in the second postnatal week. By postnatal day
24, PR outer segments were disorganized in line c (Fig. 2C).
PR cell death continued with age in this line, until at 3 months
75% of the PRs were lost (Fig. 2F). At 6 months, only a single
layer of PR nuclei remained (Fig. 2I).
Line b expressed an 8-fold lower level of bcl-2, and mor-
phological differences were not observed between this line and
the wild-type retina in the first postnatal month (compare Fig.
2 B and A). Increased PR apoptosis in line b was observed,
however, in the months that followed, albeit at a much slower
rate than in line c (compare. Fig. 2 B and E to A and D,
respectively). A slight thinning of the PR layer ("20%) was
evident by 6 months of age in line b (compare Fig. 2 H to G).
We are examining older retinas to document the time course
of degeneration in this line.
Retinal degeneration began in the homozygotic transgenic
mice from line b in the first postnatal month and proceeded at
a rate similar to that of transgenic line c (data not shown).
Thus, excessive overexpression of bcl-2, due either to higher
levels of expression (line c) or the homozygous genotype of line
b, resulted in relatively severe retinal degeneration.
For light damage studies, bcl-2 heterozygotes (line b) were
crossed to the albino BALB/c mice. In cyclic light, these
animals showed the subtle degenerative changes of the line b
founders at 2 months of age, as described above. At 4-6
months of age, there were little further degenerative changes.
Thus, the destructive effect of a single copy of the bcl-2
transgene in the line b mice, crossed to BALB/c mice, may act
only for a relatively short time.
bcl-2 Reduces Apoptosis in Photoreceptors Expressing Mu-
tant Opsin. In a previous study, we created lines of transgenic
mice that expressed a mutant form of rhodopsin (15, 20). The
S334ter is a COOH-truncated form of rhodopsin with the
terminal phosphorylation sites deleted. Mice expressing high
levels of this mutant rhodopsin lost >95% of their PRs within
3 postnatal weeks (15). The development of the retinal de-
generation phenotype cosegregated with the transgene as an
autosomal dominant trait.
We crossed bcl-2 transgenic mice to mice expressing mutant
opsin to generate double heterozygotes for bcl-2 and S334ter
(bcl-2/- and S334ter/-). Mice from both bcl-2 transgenic
lines b and c were crossed, and no discernible differences
between these two lines were observed. Overexpression of
bcl-2 reduced apoptotic cell death in the retina of mice
expressing truncated opsin by >80% in the initial 2 postnatal
weeks (Fig. 3). Numerous cells with uniform nuclear staining
with 4',6-diamidino-2-phenylindole (DAPI) were present in
the PR layer of the retina expressing the mutant rhodopsin.
The cells that have not released the nuclease showed hetero-
chromatic nuclear staining. In contrast, the retina of siblings
heterozygous for bcl-2 and S334ter had few apoptotic nuclei.
The thickness of the PR cell layer was similar to wild-type
siblings, and most PR nuclei showed the heterochromatic
staining pattern characteristic of a living cell (data not shown).
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DNA laddering assays confirmed the reduction of apoptosis in
S334ter mice by overexpression of bcl-2 (Fig. 3D).
The effect of bcl-2 on apoptosis was temporary, as the PRs
continued to degenerate, but at a reduced rate. Animals from the
b line were used to study the long term effect of bcl-2 on cell
survival. At 4 postnatal weeks, retinas of mice expressing the
mutant opsin alone possessed a single row of PR nuclei. Mice
expressing both the mutant opsin and bcl-2 retained about 25%
of their original complement of PRs. By 3 months of age,
however, the retinal morphology of the bcl-2 positive S334ter and
the S334ter siblings were indistinguishable (data not shown).
bcl-2 Inhibits Photoreceptor Cell Death in rd mice. To examine
the effect of bcl-2 on an autosomal recessive retinal degeneration,
we crossed bcl-2 positive mice from line b to rd/rd mice. There
was a rapid loss of rod PRs between postnatal day 7 and 14 in
rd/rd with and without the bcl-2 transgene. In this period, '50%
of the PRs died by apoptosis (Fig. 4). This rapid cell death
continued in rd/rd mice, reducing the retina to a single layer of
cone nuclei by postnatal day 30. There was less cell death in bcl-2
transgenic rd/rd mice (Fig. 4). At postnatal day 16, rd/rd mice
overexpressing bcl-2 had 50% more PRs than nontransgenic
littermates, and by day 19, they had several-fold more PRs (Fig.
4). By postnatal day 40, however, retinas in the rd/rd bcl-2 mice
were identical to transgene negative littermates, with few nuclei
remaining in the ONL (Fig. 4).
FIG. 1. (A) Western blot illustrat-
ing different levels of human Bcl-2 in
transgenic S334ter lines b and c. A
densitometric scan of the immunoblots
demonstrated an 8-fold greater level of
Bcl-2 protein in transgenic line c com-
pared with line b. (B) Electron micro-
scope immunocytochemistry. Bcl-2
immunoreactivity was found exclu-
sively in the synaptic terminals of rod
PRs. A 10-nM colloidal gold label is
observed in the cytoplasm of the syn-
apse, above the synaptic ribbon.
(X 19,000.) (C) Light microscope im-
munocytochemistry. Bcl-2 immunore-
activity is exclusively localized to the
outer plexiform layer of the retina.
(Bar = 25 ,tM.)
bcl-2 Protects Photoreceptors from Apoptosis Caused by
Constant Light. We studied the effects of bcl-2 overexpression
on light damage in albino BALB/c mice. We compared the
effects of 14 days of continuous illumination on albino wild-
type and transgenic mice. Prior to light damage, mice were
reared in cyclic light. Nontransgenic siblings reared in cyclic
light had normal retinas with 9-10 rows of PR nuclei in the
ONL, and inner and outer segments were of normal length and
caliber (Fig. SA). Fourteen days of constant light caused a
severe loss of PRs in these animals. In the most degenerated
central region of the superior hemisphere, the ONL was
reduced to 0-2 rows of nuclei (Fig. SB). We scored the degree
of degeneration in 52 nontransgenic siblings, and found that
the range of degeneration across animals (Fig. SE) was as
typically observed in inbred BALB/c mice (27).
Mice carrying the bcl-2 transgene exhibited subtle degenerative
changes in cyclic light as noted above. Thus at 2 months of age,
the ONL was reduced to -7-8 rows of nuclei (Fig. SC), and the
number of pyknotic nuclei appeared greater than in normal
wild-type littermates. In addition, the PR inner and outer seg-
ments were shorter and often more disorganized than normal
(compare Fig. S A and C). Nevertheless, the bcl-2 transgene
protected the PRs from the damaging effects of constant light.
Typically, 3-S rows of PR nuclei remained in the most degener-
ated region of the ONL after 14 days of constant light (Fig. SD).
The degree of degeneration was far less in 46 light-damaged bcl-2
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FIG. 2. High-level bcl-2 expression causes apo-
ptosis in PRs. Light micrographs of retinas from
wild-type (Left), line b transgenic mice (Middle),
and line c transgenic mice (Right) at different ages.
(A-C) Twenty-four days of age. (D-F) Three
months of age. (G-I) Six months of age. In line b,
there is a loss of.20% of PRs by 6 months of age(H), whereas in line c there is a loss of most PRs
by 3 months of age (F). (Bar = 25 ,um.)
H
transgenic mice than in the wild-type littermates (Fig. SE). The
mean scores (±SD) of the degree of degeneration of the wild-
type (2.35 ± 0.81) versus bcl-2 positive (3.41 ± 0.77) mice were
significantly different (P < 0.0001).
DISCUSSION
bcl-2 Modulates on Inherited Retinal Degeneration. This
investigation has established the effectiveness of bcl-2 in
promoting survival of PRs in three different models of retinal
degeneration. Our results in PRs are consistent with the notion
that bcl-2 functions as a general inhibitor of apoptotic cell
death in neurons. These findings suggest that there is a final
common pathway in the retinal degenerations, and that these
degenerations may someday be treatable by inhibiting the
entry of PRs into apoptosis.
The effects of bcl-2 on PRs were tested in a model of exper-
imentally induced cell death caused by mutant opsin. In this
transgenic mouse line, retinal pathology is remarkably similar to
that observed in patients with autosomal dominant retinitis
pigmentosa (9, 10). In this model, expression of C-terminal
truncated opsin in the PRs rapidly triggers cell death by apoptosis.
Damage to the PR likely results from the inability of the cell to
appropriately sort the mutant opsin protein in the PRs (16, 17).
Overexpression ofbcl-2 significantly extended the survival of PRs
expressing the mutant opsin. At 4 postnatal weeks, transgenic
mice expressing both bcl-2 and mutant opsin transgenes showed
a 25% reduction in PR cell death.
Similarly, PRs in rd/rd mice overexpressing bcl-2 survived
the damaging effects of a defective phosphodiesterase signif-
icantly longer than did nontransgenic siblings. In rd/rd mice, a
null mutation in the PDE f3 subunit gene leads to a nonfunc-
tional cGMP-PDE enzyme in rods. The deficiency in PDE
activity leads to cyclic GMP accumulation that rapidly dam-
ages rod PRs (28). Rods in the rd/rd retina overexpressing
bcl-2 survived the damaging effect of elevated cGMP for 2-3
times longer than nontransgenic rd/rd littermates.
There was, however, the same rapid loss of rod PRs between
postnatal day 7 and 14 in rd/rd mice carrying the bcl-2 transgene
as in nontransgenic siblings. In rd/rd mice without the bcl-2
transgene, this loss of rods continued at a rapid rate until there
were no surviving rod cells at postnatal day 30. In bcl-2 overex-
pressors, however, this rod cell loss lessened between postnatal
day 14 and 40. There are several possible explanations for the two
phases of cell death. It may be that the amount of bcl-2 provided
by the transgene at days 5-14 is insufficient to generate the rescue
effect. There may also be multiple mechanisms of cell death at
work in the PRs. Answering these questions will require a careful
study of the relationship between the bcl-2 level in the receptors
and the rescue effect.
Despite the established nature of the genetic defects in these
two models, a key unresolved question is how the expression
of the mutant opsin or the lack of a functional phosphodies-
terase signals the initiation of apoptosis in the PRs. There is no
evidence that overexpression of bcl-2 altered the disease
mechanism initiated by these genetic defects. However, the
action of bcl-2 significantly increased the period in which PRs
survived these degenerative processes.
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FIG. 3. Protective effect of bcl-2 on apopto
of retinas from mice that are (A) wild-type, (
the bcl-2 overexpressing mouse (C) is signific.
of bcl-2. (Bar = 25 ,um.) (D) DNA laddering at
mice, significantly more in S334ter transgenic n
Effect of bcl-2 on Photoreceptor Inj
Light. In the two models of inherited de
above, the PRs incurred continuous dan
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single 14-day light exposure. Mice over
played the damaging effects of light expo
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creased the number of surviving PRs.
In previous studies (29, 30), injectioi
growth factor protected PRs from cell de
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these PRs showed excellent anatomical re
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FIG. 4. Morphometric counts of surviving ]
overexpressing bcl-2. A minimum of three bE
nontransgenic rd/rd mice were examined at eac
counted in a 180-,um linear expanse of the oute
are averages from five 1-j±m sections through I
of the retina from each mouse. Following an i]
PR nuclei during the first 7-12 postnatal days, I
the wild-type (+/+) retina, there is a relativel
thinning of the ONL. A rapid thinning of the (
retinas of both the rd/rd mice and rd/rd mice wi
between about days 7-14. Thereafter, the loss
in the bcl-2 overexpressing mice than in the rt
tic cell death induced by mutant opsin in line b transgenic mice at postnatal day 11. Light micrographs
B) S334ter mutant opsin transgenic or (C) double heterozygous for mutant opsin. The ONL from
antly thicker than that of the mouse without bcl-2 overexpression (B), indicating a protective effect
ssay showing little DNA laddering in control retinas, a slightly greater than normal in bcl-2 transgenic
nice with mutant opsin, and significantly reduced laddering in S334 mice that overexpress bcl-2 (cross).
jury from Constant days following a 7-day exposure to constant light, the inner
generation described segments were healthier and the outer segments had reformed.
nage from the muta- Similarly, we expect that the survival-enhancing effect of bcl-2
were subjected to a will allow PRs to recover and regenerate outer segments, but
expressing bcl-2 dis- this remains to be shown.
isure as did nontrans- Excessive Expression of bcl-2 Can Decrease Photoreceptor
bcl-2 significantly in- Survival. A potentially important finding in the bcl-2 mice is that
high level expression ofbcl-2 increased cell death in wild-type PRs.
n of basic fibroblast This effect was dose-dependent, occurring to a greater degree in
.ath during a damag- heterozygous mice of line c that expressed 8-fold higher levels of
g the light exposure, bcl-2 and in transgenic homozygotes of line b than in heterozy-
,covery. That is, at 10 gous mice of line b. The bcl-2 transgene did not result in the death
of other retinal cells, suggesting that the PR cell death was a direct
consequence of bcl-2 expression. This appears to be a specific
-6 rd/d effect of bcl-2 because no effect on cell death was observed when
the same rhodopsin promoter-expression construct was used to
v- rd/rd bd2 express lac z (22), or rod or cone transducin (31). The mechanism
6 ,/, underlying the PR damaging effect of increased bcl-2 is unclear.
One possibility may be that bcl-2 overexpression disrupted the
balance of heterodimers, such as Bcl-2/Bax, which may be the
effective complex in cell survival.
We also found a limited duration for the survival-promoting
effect ofbcl-2 in the two models of inherited retinal degeneration.
There are several different explanations for this variation in the
effectiveness of bcl-2. It may be that the negative effects of
increased bcl-2 in the PR eventually dominate its survival pro-
moting function. In addition, there may be changes in the
expression of Bcl-2 related proteins (e.g., Bag, Bax) that com-35 40 45 50 pensate for overexpression ofbcl-2 and limit the effectiveness and
duration of the bcl-2 protective effect. Overall, our results suggest
PRs in the rd/rd mouse there may be a complex cell death regulatory network in PRs and
cl-2 positive and three that bcl-2 functions in conjunction with a family of apoptosis-
h point. PR nuclei were promoting and inhibiting gene products. Moreover, the mecha-
r nuclear layer. Counts nism of linking injury and the initiation of apoptosis in PRs
the most central region remains unclear. The bcl-2 overexpressing mice should be useful
nitial rise in number of in further studies on PRs that uncover the mechanisms of retinal
loss of nuclei occurs. In degenerative disease and the action of the bcl-2 family of proteins.
ONL is observed in the In conclusion, the present investigation demonstrates thatOthbl-2 overexpression PRs overexpressing bcl-2 survive genetic or light-induced
of PR nuclei is slower insults longer than PRs with normal endogenous levels of bcl-2.
d/rd mice. Despite the degenerative changes produced by overexpression
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FIG. 5. Protective effect of bc-l-2 in light damage. Light
micrographs of retinas of littermate albino mice eithel
wild-type (A aind B) or carrying the bcl-2 transgene (C <and
DJ). (A) Wild-type motuse at 2 months of age maintained in
cyclic light illustrating a normal retinaz. (B) Wild-type
mouse after 14 days of constant light. The ONL has been
reduced to 1-2 rows of PR nuclei, and ailmost no inner and
outer segments are present. (C) Mouse carrying the h(cl-2
transgenc maintlained in cyclic light. The ONL has been
reduced to 7-8 rows of nuclei and the PR inner and outer
segments arc shorter than normal (compare with A). (D)
Mouse carryving the bcl-2 transgene alfter 14 days of con-
stant light. The ONL consists of 3-4 rows of nuclei, and
short inner and outer segments are present. Toluidine blue.
(Bar = 25 Am.) (k) Frcquency distribution of dcgrcc of
degenerationi (1 = maximal degeneration; 5 = least de-
generation) of albino mice exposed to 14 days of constant
light. The wild-type mice (open bars) showed significantly
more degeneration than did those carrying thc bcl-2 trans-
gene (solid hars).
of the bcl-2 transgene itself, it clearly protects PRs from genetic
and environmental insults. These results strongly support the
idea that blocking the entry of PRs into apoptosis may delay
or prevent retinal degeneration.
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